Search - tctmd.com

Displaying 221 - 240 of 1986

Sort: Relevancy | Date

Presentation NY Valves 2024

Is That in My Way? The Interventional Cardiologist's Perspective

Presenter: Bruce J. Rutkin

June 07, 2024

Presentation NY Valves 2024

Seeing Is Believing: The Importance of Imaging of CIEDs in Lead-Tricuspid Valve Interactions

Presenter: Elana Koss

June 07, 2024

Presentation NY Valves 2024

Device Selection and Procedural Technique: A Step-By-Step Guide

Presenter: Vinayak N. Bapat

June 07, 2024

Presentation NY Valves 2024

First-In-Human Experience With a Novel Vascular Closure Device for Large-Bore Arterial and Venous Closures (X Dot)

Presenter: Vivian G. Ng

June 07, 2024

Presentation NY Valves 2024

First-in-Human Experience With the EnCompass F2 Filter, a Novel Cerebral Embolic Protection Device for TAVR

Presenter: Tamim M. Nazif

June 07, 2024

Presentation NY Valves 2024

Device-Related Thrombus Post-LAAO: Diagnosis, Prevention, & Management

Presenter: Amit N. Vora

June 07, 2024

Presentation NY Valves 2024

A Cutting-Edge Polyphenol-Based Coating Technology for the Third Generation of Polymer Heart Valves (BCI Technology)

Presenter: Isaac George

June 07, 2024

Presentation NY Valves 2024

Innovation With a Novel Polymer Heart Valve (TRIA) Portfolio (FOLDAX)

Presenter: Steven J. Yakubov

June 07, 2024

Presentation NY Valves 2024

Transcatheter Aortic Valve Repair for Aortic Insufficiency Using the Cusper Device (Cuspa)

Presenter: Yair Feld

June 07, 2024

Presentation NY Valves 2024

Treatment of LAAO Peri-Device Leak: Transcatheter Options

Presenter: Rodney Horton

June 07, 2024

Presentation NY Valves 2024

Partner Valves: Role of a Prospective Device Selection Strategy Using Acurate and SAPIEN 3 as Complementary Devices in Transcatheter Aortic Valve Replacement

Presenter: Jonathan Michel

June 07, 2024

Presentation NY Valves 2024

Report of an IDE Pivotal Study of a Dedicated Leaflet Splitting Device During TAVR (SHORTCUT)

Presenter: Susheel K. Kodali

June 07, 2024

Presentation NY Valves 2024

When is Post-LAAO Peri-Device Leak Significant?

Presenter: Christine J. Chung

June 07, 2024

Presentation NY Valves 2024

Percutaneous Treatment of Tricuspid Regurgitation With the Novel TriFlO® Device: First in Human Italian Experience

Presenter: Gian Paolo Ussia

June 06, 2024

Presentation NY Valves 2024

Next Generation LAAO Devices: Mechanisms, Unmet Needs, and Clinical Status

Presenter: Horst Sievert

June 06, 2024

Presentation NY Valves 2024

Innovative Approaches: Solving ASD Device Retrieval Challenges Beyond the Cath Lab Norm

Presenter: Adam Habib

June 06, 2024

Presentation NY Valves 2024

Heterotopic TTVR in Patients With Severe TR: First-in-Human Experience With the Trillium Device

Presenter: Philipp Lurz

June 06, 2024

Presentation NY Valves 2024

Current Status of LAAO in the United States: Device Utilization, Indications, and Clinical Outcomes

Presenter: Matthew J. Price

June 06, 2024

News Conference News NY Valves 2024

Risk Score IDs Patients Safe for Same-Day Discharge After Low-Risk TAVI

Michael O'Riordan

June 06, 2024

Presentation NY Valves 2024

Standard Techniques for LAAO Device Implantation – Lessons Learned Over a Decade

Presenter: Reda Ibrahim

June 06, 2024

Advertisement

Is That in My Way? The Interventional Cardiologist's Perspective

Seeing Is Believing: The Importance of Imaging of CIEDs in Lead-Tricuspid Valve Interactions

Device Selection and Procedural Technique: A Step-By-Step Guide

First-In-Human Experience With a Novel Vascular Closure Device for Large-Bore Arterial and Venous Closures (X Dot)

First-in-Human Experience With the EnCompass F2 Filter, a Novel Cerebral Embolic Protection Device for TAVR

Device-Related Thrombus Post-LAAO: Diagnosis, Prevention, & Management

A Cutting-Edge Polyphenol-Based Coating Technology for the Third Generation of Polymer Heart Valves (BCI Technology)

Innovation With a Novel Polymer Heart Valve (TRIA) Portfolio (FOLDAX)

Transcatheter Aortic Valve Repair for Aortic Insufficiency Using the Cusper Device (Cuspa)

Treatment of LAAO Peri-Device Leak: Transcatheter Options

Partner Valves: Role of a Prospective Device Selection Strategy Using Acurate and SAPIEN 3 as Complementary Devices in Transcatheter Aortic Valve Replacement

Report of an IDE Pivotal Study of a Dedicated Leaflet Splitting Device During TAVR (SHORTCUT)

When is Post-LAAO Peri-Device Leak Significant?

Percutaneous Treatment of Tricuspid Regurgitation With the Novel TriFlO® Device: First in Human Italian Experience

Next Generation LAAO Devices: Mechanisms, Unmet Needs, and Clinical Status

Innovative Approaches: Solving ASD Device Retrieval Challenges Beyond the Cath Lab Norm

Heterotopic TTVR in Patients With Severe TR: First-in-Human Experience With the Trillium Device

Current Status of LAAO in the United States: Device Utilization, Indications, and Clinical Outcomes

Risk Score IDs Patients Safe for Same-Day Discharge After Low-Risk TAVI

Standard Techniques for LAAO Device Implantation – Lessons Learned Over a Decade

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content